Lenvatinib Mesylate and Metoprolol and hydrochlorothiazide
Determining the interaction of Lenvatinib Mesylate and Metoprolol and hydrochlorothiazide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: hydrochlorothiazide / metoprolol
Brand name: Dutoprol, Lopressor HCT
Synonyms: Hydrochlorothiazide and metoprolol, Metoprolol and Hydrochlorothiazide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Metoprolol and Hydrochlorothiazide Extended-Release Tablets
- Lenvatinib Mesylate-Metoprolol and Hydrochlorothiazide Tablets
- Lenvatinib Mesylate-Metoprolol Extended-Release Capsules
- Lenvatinib Mesylate-Metoprolol Extended-Release Tablets
- Lenvatinib Mesylate-Metoprolol Injection
- Lenvatinib Mesylate-Metoprolol Intravenous
- Metoprolol and hydrochlorothiazide-Lenvima
- Metoprolol and hydrochlorothiazide-Lenvima (14 MG Daily Dose)
- Metoprolol and hydrochlorothiazide-Lenvima (18 MG Daily Dose)
- Metoprolol and hydrochlorothiazide-Lenvima (20 MG Daily Dose)
- Metoprolol and hydrochlorothiazide-Lenvima (24 MG Daily Dose)
- Metoprolol and hydrochlorothiazide-Lenvima (8 MG Daily Dose)